|
|
|
|
LEADER |
01000naa a22002652 4500 |
001 |
NLM344946800 |
003 |
DE-627 |
005 |
20231226023934.0 |
007 |
cr uuu---uuuuu |
008 |
231226s2022 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1021/acs.langmuir.2c01199
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1149.xml
|
035 |
|
|
|a (DE-627)NLM344946800
|
035 |
|
|
|a (NLM)35976036
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Ishimoto, Arisa
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Drug-Loaded Nanocarriers Composed of Cholesteryl Oleate Crystal Cores and Multiple-Nanosheet Shells of γ-Cyclodextrin Inclusion Complex Crystals
|
264 |
|
1 |
|c 2022
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 31.08.2022
|
500 |
|
|
|a Date Revised 13.10.2022
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a In this study, we prepared drug-loaded nanocarriers made of cholesteryl oleate (ChO) and γ-cyclodextrin (γ-CD). A nanosuspension (nanosuspension-I, NS-I) containing nanoparticles with a mean size of approximately 170 nm was obtained through the solvent-diffusion method using ethanol. A second nanosuspension (nanosuspension-II, NS-II), which was prepared by freeze-drying and redispersion of NS-I, exhibited an increased particle size of approximately 210 nm. Cryogenic transmission electron microscopy (cryo-TEM) and atomic force microscopy (AFM) force-distance curves indicated that the nanoparticles in NS-I were oblong and soft. However, those in NS-II were angular and stiff, and, interestingly, multiple nanosheets covered the solid-liquid interface. Synchrotron wide-angle X-ray diffraction (WAXD) analysis of NS-II indicated that the nanoparticles in it had a core-shell structure, where the ChO crystal in the inner core was covered by multiple nanosheets of ChO/γ-CD inclusion complex crystals. The X-ray peak analysis suggested that the γ-CD columns of the nanosheets were vertically stacked onto the ChO crystal interface. It was found that the nanosheets on the nanoparticle interface were formed during the freezing process. A model drug carbamazepine (CBZ) was loaded into the ChO/γ-CD nanoparticles by pre-dissolving CBZ in ethanol during the solvent-diffusion process. Cryo-TEM, 1H NMR, ζ-potentials, and synchrotron WAXD indicated that CBZ was unexpectedly loaded into the shell as a CBZ/γ-CD inclusion complex crystalline nanosheet. The specific nanosheet structure, where ChO and CBZ coexisted in the same crystal of γ-CD, could achieve CBZ loading in the nanoparticles. ChO/γ-CD nanoparticles with the unique core-shell structure are expected to perform as practical carriers for drug delivery
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
650 |
|
7 |
|a Cholesterol Esters
|2 NLM
|
650 |
|
7 |
|a Pharmaceutical Preparations
|2 NLM
|
650 |
|
7 |
|a Solvents
|2 NLM
|
650 |
|
7 |
|a gamma-Cyclodextrins
|2 NLM
|
650 |
|
7 |
|a cholesteryl oleate
|2 NLM
|
650 |
|
7 |
|a 3DPK9KFN2M
|2 NLM
|
650 |
|
7 |
|a Ethanol
|2 NLM
|
650 |
|
7 |
|a 3K9958V90M
|2 NLM
|
700 |
1 |
|
|a Sasako, Hiroshi
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Omori, Masaki
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Higashi, Kenjirou
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Ueda, Keisuke
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Koyama, Kazuo
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Moribe, Kunikazu
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Langmuir : the ACS journal of surfaces and colloids
|d 1999
|g 38(2022), 34 vom: 30. Aug., Seite 10454-10464
|w (DE-627)NLM098181009
|x 1520-5827
|7 nnns
|
773 |
1 |
8 |
|g volume:38
|g year:2022
|g number:34
|g day:30
|g month:08
|g pages:10454-10464
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1021/acs.langmuir.2c01199
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_721
|
951 |
|
|
|a AR
|
952 |
|
|
|d 38
|j 2022
|e 34
|b 30
|c 08
|h 10454-10464
|